Biotin for Hair Growth: Marketing vs Reality
Biotin (vitamin B7) is a multi-billion-dollar category sold for thicker hair and stronger nails, but the evidence only supports a benefit in people who are genuinely biotin-deficient — and true deficiency is rare in well-fed adults. There are no solid placebo-controlled trials showing it grows hair in biotin-sufficient people; once your tissue stores are full, the excess is simply excreted in urine. The more important issue is safety: the common 5,000–10,000 mcg "hair, skin and nails" doses can throw off many lab tests, including thyroid panels and troponin, and the FDA has warned of falsely low troponin masking a heart attack, with at least one death. If you take high-dose biotin, the practical advice is to stop it two to three days before any blood work.
Beauty influencers endorse it and pharmacy shelves are full of it, yet the clinical evidence supports a hair or nail benefit from biotin only in people who are biotin-deficient to begin with — and true biotin deficiency is rare in well-fed adults. That single fact undercuts almost the entire marketing case.
What Biotin Actually Does
Biotin is a B-vitamin cofactor for several carboxylase enzymes used in fat synthesis, amino acid metabolism, and gluconeogenesis. Hair follicles are metabolically active and need biotin for keratin production. When biotin is truly deficient — for example in people with biotinidase deficiency or holocarboxylase synthetase deficiency, in those eating large amounts of raw egg whites (which contain avidin, a biotin-binding protein), in people on long-term anticonvulsants, or in some intestinal disorders — hair loss, scaly rash around the eyes, nose, and mouth, and brittle nails are classic features. Replacing the missing biotin reverses those changes.
The leap the supplement industry has made is to assume that if deficiency causes hair loss, then extra biotin will supercharge hair growth. That is not how water-soluble vitamins work. Once tissue stores are saturated, excess biotin is largely excreted in urine. Most people on a normal Western diet are already at or near saturation.
The Clinical Trial Evidence
There are no well-designed, placebo-controlled RCTs showing that biotin supplementation improves hair growth in biotin-sufficient adults. Most studies cited in marketing materials are case reports of deficient patients, small observational studies without controls, or trials of multi-ingredient supplements that contain biotin alongside other actives, making it impossible to credit biotin specifically.
A 2017 review in Skin Appendage Disorders by Patel and colleagues examined the published evidence and concluded that every reported case in which biotin appeared to help hair or nails involved an underlying biotin deficiency or a condition known to affect biotin metabolism.
The Diagnostic Interference Problem
High-dose biotin supplements — the 5,000 to 10,000 mcg "hair, skin and nails" products are common — can interfere with many immunoassay-based laboratory tests, including thyroid panels, troponin (a heart-attack marker), and several hormone assays. The U.S. Food and Drug Administration has issued safety communications warning that biotin can cause falsely low troponin results, with at least one death in a patient whose heart attack was missed. Beyond being unproven for hair, high-dose biotin is a genuine medical hazard around the time of laboratory testing; clinicians typically advise stopping it for 2 to 3 days before blood draws.
Sources
- Patel DP, Swink SM, Castelo-Soccio L. "A Review of the Use of Biotin for Hair Loss." Skin Appendage Disorders, 2017;3(3):166-169. PMID 28879195.
- U.S. Food and Drug Administration. "The FDA Warns that Biotin May Interfere with Lab Tests: FDA Safety Communication." November 5, 2019 (updated). FDA.gov.
- Zempleni J, Hassan YI, Wijeratne SS. "Biotin and biotinidase deficiency." Expert Review of Endocrinology & Metabolism, 2008;3(6):715-724. PMID 19727438.
- Soleymani T, Lo Sicco K, Shapiro J. "The Infatuation With Biotin Supplementation: Is There Truth Behind Its Rising Popularity? A Comparative Analysis of Clinical Efficacy versus Social Popularity." Journal of Drugs in Dermatology, 2017;16(5):496-500. PMID 28628687.
Reviewed against 4 peer-reviewed sources.